| Ms Cara Cadigan, | |
|
300 Longwood Ave, Farley 6, Boston, MA 02115-5724 | |
| (617) 355-6000 | |
| Not Available |
| Full Name | Ms Cara Cadigan |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003296187 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 20540 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Cara Cadigan, 300 Longwood Ave, Farley 6, Boston, MA 02115-5724 Ph: () - | Ms Cara Cadigan, 300 Longwood Ave, Farley 6, Boston, MA 02115-5724 Ph: (617) 355-6000 |
News Archive
An intervention in primary care settings that allowed a choice of cognitive behavior therapy, medication, or both, along with computer-assisted treatment support for patients with common anxiety disorders, resulted in greater improvement in anxiety symptoms and functional disability compared to usual care, according to a study in the May 19 issue of JAMA, a theme issue on mental health.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of new sizes of its Matryx™ Biocomposite Interference Screw. These new screws represent the latest advance in biocomposite material technology that allows CONMED Linvatec to produce the smallest Biocomposite Interference screw available on the market today for primary fixation of ACL and PCL grafts.
The Centre for Brain Research at the MedUni Vienna is regarded as a world leader in researching the mechanisms involved with multiple sclerosis (MS). Now, in a paper published in the highly respected journal Lancet Neurology, an international team of researchers from Edinburgh, Cleveland and Vienna, under the leadership of Hans Lassmann, Head of the Department of Neuroimmunology at the MedUni Vienna, has for the first time documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play.
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has been approved by the United States Drug Enforcement Agency for the analysis of Schedules I through V controlled substances, complementing its existing license to develop and manufacture drug products containing Schedules IV and V controlled substances.
EpiCept Corporation announced today the publication of a new meta-analysis which concluded that interleukin-2 (IL-2) monotherapy is not effective as a maintenance therapy for acute myeloid leukemia (AML) patients in first complete remission. These results were published in the July 7, 2011 edition of Blood, a leading scientific journal in hematology.
› Verified 4 days ago
Mr. James Joseph Gaydos, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 125 Parker Hill Avenue, Boston, MA 02120 Phone: 617-754-5500 | |
Miss Lauren Ashley Masterson, P.T., D.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-7216 | |
Caitlin Marie Martin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 85 Franklin St, Boston, MA 02110 Phone: 857-284-4399 Fax: 847-233-2642 | |
Kelley Morgan, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4 Avery St, Boston, MA 02111 Phone: 617-247-2300 | |
Dr. Brittany Bobik Lowey, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3 Worcester Sq, Unit 2, Boston, MA 02118 Phone: 302-229-3529 | |
Miss Bryana Carey, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 Parkman St, Boston, MA 02114 Phone: 617-643-4373 |